The copper-catalyzed ring opening of chiral-pool-derived 1,1′-diBoc-2,2′-biaziridine with Grignard reagents affords enantiopure 2-imidazolidinones in a desymmetrizing, cascade process involving the Boc protecting group. This divergent strategy provides reaction-ready, N-differentiated products and allows two C-C bond constructions concurrent to imidazolidinone formation. A variety of alkyl, cyclic, and aryl Grignard reagents are tolerated in reasonable to good yields. 
peptidomimetics, 2 as well as chiral ligands 3 and auxiliaries 4 in stereoselective synthesis (e.g., 1−4, Figure 1 ). Additionally, these five-membered cyclic ureas are precursors to other useful compound classes including vicinal diamines, 5 cyclic guanidines 6 and imidazolidinethiones. 7 Although the traditional route to this heterocycle involves treatment of a vicinal diamine with an electrophilic carbonyl source, 8 an abundance of alternate methods are now available which avoid the requirement for pre-synthesized diamines, offering greater product diversity in modular fashion. 9 Despite these advances however, there remains comparatively few general methods which allow access to 4-and/or 5-substituted 2-imidazolidinones with control of absolute stereochemistry. Previously in our laboratory, as an intermediary step towards the synthesis of 2,2'-biindoline, we attempted the ring opening of tartaric acid-derived biaziridine 5 with a Grignard reagent, affording an imidazolidinone 6a as the major product arising from an unforeseen participation of the Boc protecting group (Scheme 1). 11 Although 5 is an easily synthesized, 12 bench-stable solid, its reactivity has remained unexplored beyond this example, thus we were inspired to further investigate the ring opening of 5 by Grignard reagents. As well as harboring the potential to prepare enantiopure 2-imidazolidinones 6 in a divergent manner, this approach would allow direct access to reaction-ready, N-differentiated products, thus presenting downstream opportunities for sequential, asymmetric Nfunctionalization. 13 Furthermore, this method would constitute a useful addition to the limited existing synthetic strategies to enantioenriched trans-4,5-disubstituted imidazolidinones, which are specific to vinyl-derivatives 14 or require multistep routes from amino acids 15 or 1,3-dihydro-2-imidazolone.
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Scheme 1. Proposed Synthesis of 2-Imidazolidinones
We began this investigation by examining the effect of reaction parameters on the product ratio, in the search for conditions favoring imidazolidinone formation (Table 1) . We were not concerned with pursuing a separate optimization of 7 in this study, as we have recently shown that the analogous tosylbiaziridine cleanly provides vicinal diamines of this type upon ring opening. 17 For convenience, we selected commercially available i-PrMgCl as the model Grignard reagent. Our initial experiment was performed under similar conditions to reported previously, 11, 17 affording a mixture of the desired heterocycle 6b and vicinal diamine 7b in a 25:75 ratio (entry 1). Immediately, we noted a clear dependency of the product ratio on the Grignard reagent, given the reversal in major product from the previous reaction (see Scheme 1). Undeterred by this result, we examined variations in the quantity of the catalyst: a reduction to 5 mol % gave a similar outcome (Table 1 , entry 2), while omitting the copper salt completely resulted in neither product being observed (entry 3). Encouragingly, when the starting concentration of 5 was reduced, the ratio of 6b:7b was increased favorably (entry 4 versus entry 1). Maintaining this concentration and removing the excess Grignard reagent 18 provided a further advantage, enabling 6b to emerge as the major product in 48% isolated yield (entry 5), along with 7b obtained in 26% yield, which was easily separated from 6b by flash chromatography due to its significantly lower polarity on silica gel.
Subsequent experiments proved unsuccessful in further optimizing the outcome; increasing the reaction time (prior to NH 4 Cl quench) had a negligible effect (entry 6), while performing slow addition of the Grignard reagent at −20 °C returned mostly unreacted 5 (entry 7).
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Although the yield of 6b was affected by the persistent formation of 7b, we remained optimistic that screening a variety of Grignard reagents would provide more favorable results, given the apparent dependency of the product ratio on the Grignard reagent. Therefore, we proceeded to examine the scope of the process under the newly established conditions (Table 2) . A range of structurally and electronically diverse Grignard reagents such as cyclic, primary alkyl and functionalized benzylic and aryl carbanions, including ortho-substituted substrates, were found to be accommodated, affording the desired imidazolidinones 6a−6p in modest to good yields (37−84%). With the majority of Grignard reagents examined, the yield of 6 was notably lower than would be expected based on the product ratio, indicating biaziridine decomposition as a competing reaction pathway. The products were purified by silica gel flash chromatography and were observed to be stable to these conditions.
Similarly to the isopropyl test substrate, clean C−C bond formation took place with the cyclohexyl Grignard reagent, but equimolar amounts of 6c and 7c were formed, resulting in a 46% yield of 6c (Table 2) . Notably, all other Grignard reagents surveyed provided higher ratios of 6:7 than observed with the secondary carbanions (isopropyl and cyclohexyl). Primary alkyl (non-methyl) and aryl Grignard reagents were particularly good performers in this regard, providing molar ratios of 6:7 in excess of 90:10 in all cases. With aryl and vinyl Grignard reagents, up to 3.6 equiv of the carbanion was required for complete consumption of 5, although not at the expense of the product ratio.
The method was revealed to be somewhat sensitive to inductive effects: the electron-rich 2-methoxyphenyl Grignard reagent furnished 6l in 80% yield (Table 2) , whereas the electron-deficient 3-chloro derivative provided 6p in a reduced 37% yield. In the latter case, a number of unidentified side products were observed. The 2-bromophenyl Grignard reagent was required in four-fold excess for complete consumption of 5, presumably due to nucleophile loss via decomposition to benzyne. 20 Under these conditions, 6a was obtained in 60% yield, with, at most, a trace of 7a formed, representing a significant improvement to our original lead result (Scheme 1). Unsuccessful substrates under the standard conditions included tert-butyl, ethynyl and 2-thienyl Grignard reagents (products not shown).
In these cases, unreacted 5 was the predominant component in the crude mixture after work-up.
NMR analysis of the products revealed some notable general characteristics. H4 was observed in all cases as an apparent triplet (δ 3.14−3.63 ppm, J = 5.7−7.4 Hz), while H5 routinely resonated further downfield as a doublet (δ 3.73−4.40 ppm, J = 7.8−10.8 Hz). These multiplicities were attributed to vicinal coupling with their adjacent methylene protons (HA and HB), as no correlations between H4 and H5 were observed by gCOSY analysis. The diastereotopic methylene protons at HA, as well as As anticipated, all evidence pertaining to the stereochemical purity of the products pointed conclusively to a complete chirality transfer from the biaziridine. The absence of diastereoisomers in the NMR spectra of all crude materials and purified products served as primary evidence against epimerization under the basic ring opening conditions. In addition, representative ring-opening product ent-6l was prepared and was found to have a specific rotation equal and opposite to 6l (Table 2 , insert). The optical purities of 6l and ent-6l were further confirmed by analytical chiral HPLC.
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A divergent reaction mechanism is proposed in Scheme 2 to account for the formation of 6 and side product 7. Initially, nucleophilic addition of the organocuprate produces common intermediate 8, which can either be attacked by a second equivalent of the carbanion to give the fully ring-opened diamine 7
(blue arrows, intermolecular pathway) or undergo an intramolecular N-acylation 22, 23 to produce bicyclic intermediate 9 (red arrows, intramolecular pathway). 24 Subsequent addition of a second equivalent of the organocuprate to 9 ultimately produces imidazolidinone 6. This mechanistic proposal is consistent with our earlier data in that the resultant ratio of 6:7 was found to increase with higher dilution and lesser equivalents of the carbanion; conditions which would be expected to favor the intramolecular pathway. Furthermore, the propensity for secondary alkyl and cyclic Grignard reagents to produce greater quantities of 7 can be rationalized by the higher reactivity of their derived organocuprates towards 8, as the rate of competing cyclization to 9 is presumably independent of the pendant R group. In an attempt to characterize the reaction products of mono-carbanion addition, we performed an experiment with a limiting amount of i-PrMgCl and maintained the temperature below −10 °C (Scheme 3). Interestingly, TLC and NMR analyses of the crude mixture did not reveal any new reaction products; only the previously characterized di-addition products 6b and 7b were present, in addition to unreacted 5 as the major component. The absence of 11 was not overly surprising, given that there are presumably two modes for the consumption of its anionic precursor 8 (see Scheme 2), but the lack of observation of 9 is more difficult to rationalize. Essentially, if 9 is formed during the ring opening process, its absence in the crude mixture suggests either its instability to the aqueous workup conditions, 26 or a significantly greater reactivity to ring opening than 5, thereby being consumed more rapidly by the available carbanion. In line with the latter, a number of related aziridine-fused (4S,5S)-2, . The title compounds were prepared according to the general procedure using 5 (40.0 mg, 0.14 mmol) and 
(4S,5S)-4,5-Di(cyclohexylmethyl)-1-tert-butoxycarbonyl-2-imidazolidinone (6c). This was prepared
according to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10. 4, 150.4, 82.0, 58.9, 51.5, 43.9, 41.0, 34.4, 34.0, 33.9, 33.5, 33.0, 32.5, 28.2, 26.4, 26.3, 26.10, 26.07; IR (neat) v 3284, 2921 IR (neat) v 3284, , 2346 IR (neat) v 3284, , 1776 IR (neat) v 3284, , 1744 IR (neat) v 3284, , 1701 IR (neat) v 3284, , 1340 IR (neat) v 3284, , 1250 IR (neat) v 3284, , 1157 
(4S,5S)-4,5-Di(cyclopropylmethyl)-1-tert-butoxycarbonyl-2-imidazolidinone (6d). This was prepared
according to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10.8 mg, 0.053 mmol) in THF (4.55 mL) and a solution of cyclopropylmagnesium bromide (0.5 M in THF, 0.85 mL, 
(4S,5S)-4,5-Di(4-pentenyl)-1-tert-butoxycarbonyl-2-imidazolidinone (6f). This was prepared according
to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10.8 mg, 0.053 mmol) in THF (4.6 mL) and a solution of but-3-en-1-ylmagnesium bromide (0.44 M in THF, 0.83 mL, 0.37 mmol). 6, 150.5, 137.93, 137.86, 115.2, 115.1, 82.1, 60.4, 53.7, 35.8, 33.4, 33.3, 33.0, 28.1, 24.1, 23.7; IR (neat) v 3309, 2931 IR (neat) v 3309, , 2358 IR (neat) v 3309, , 1773 IR (neat) v 3309, , 1700 IR (neat) v 3309, , 1340 IR (neat) v 3309, , 1249 IR (neat) v 3309, , 1157 
(4S,5S)-4,5-Di(4-benzyloxybutyl)-1-tert-butoxycarbonyl-2-imidazolidinone (6g). This was prepared
according to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10.8 mg, 0.053 mmol) in THF (3.9 mL) and a solution of 3-benzyloxypropylmagnesium bromide (0. 4, 150.4, 138.40, 138.36, 128.31, 128.30, 127.60, 127.56, 127.51, 127.48, 82.1, 72.90, 72.87, 69.8, 69.7, 60.4, 53.6, 36.2, 33.3, 29.5, 29.4, 28.1, 21.6, 21.1; IR (neat) v 3929, 2858 IR (neat) v 3929, , 2360 IR (neat) v 3929, , 1773 IR (neat) v 3929, , 1696 IR (neat) v 3929, , 1457 IR (neat) v 3929, , 1340 IR (neat) v 3929, , 1249 IR (neat) v 3929, , 1098 ; HRMS (ESI) calcd for C 30 7, 150.2, 140.0, 139.9, 132.91, 132.88, 130.4, 130.2, 128.0, 127.9, 127.7, 127.6, 124.2, 82.3, 60.0, 53.0, 36.5, 33.7, 31.7, 31.2, 28.1; IR (neat) v 3298, 2966 IR (neat) v 3298, , 2360 IR (neat) v 3298, , 1772 IR (neat) v 3298, , 1472 IR (neat) v 3298, , 1340 IR (neat) v 3298, , 1249 IR (neat) v 3298, , 1154 IR (neat) v 3298, , 1022 ; HRMS (ESI) calcd for 5, 150.4, 136.2, 136.0, 118.0, 117.7, 82.1, 59.8, 53.0, 34.7, 31.7, 28.1, 25.8, 18.1, 18.0; IR (neat) v 3287, 2979 IR (neat) v 3287, , 2360 IR (neat) v 3287, , 1769 IR (neat) v 3287, , 1340 IR (neat) v 3287, , 1249 IR (neat) v 3287, , 1157 (4S, . This was prepared according to the 0, 150.1, 136.0, 135.8, 129.2, 128.9, 128.69, 128.65, 126.82, 126.79, 82.5, 60.7, 53.5, 42.0, 39.1, 28.1; IR (neat) v 1762 IR (neat) v , 1490 IR (neat) v , 1340 IR (neat) v , 1152 IR (neat) v , 1061 IR (neat) v , 1022 ; HRMS (ESI) calcd for 4S, . This was prepared according to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10.8 mg, 0.053 mmol) in THF (3.52 mL) and a solution of 2-bromophenylmagnesium chloride (0.6 M in THF, 1.88 mL, 1.13 mmol). Flash chromatography (2.0 g silica, 30% EtOAc/hexanes) gave 6a (44.3 mg, 60%) as a pale yellow gum. Spectral data for 6a was consistent with that reported previously.
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( 4S, . This was prepared according to the general procedure using 5 (40.0 mg, 0.14 mmol) and 6, 157.3, 155.3, 150.4, 131.4, 130.9, 128.1, 128.0, 124.6, 124.5, 120.4, 120.3, 110.21, 110.18, 81.9, 59.0, 55.0, 54.9, 51.6, 37.1, 34.1, 28.2; IR (neat) v 2921 IR (neat) v , 1776 IR (neat) v , 1492 IR (neat) v , 1351 IR (neat) v , 1250 IR (neat) v , 1153 IR (neat) v , 1117 IR (neat) v , 1026 (4R, . This was prepared according to the general procedure using ent-5 (40.6 mg, 0.14 mmol) and CuBr·SMe 2 (14.2 mg, 0.069 mmol) in THF (4.78 mL) and a solution of 2-methoxyphenylmagnesium bromide (0.46 M in THF, 0.92 mL, 0.42 mmol). Flash chromatography (2.0 g silica, 30% EtOAc/hexanes) gave ent-6l (51.3 mg, 84%) as a white solid. Spectral data for ent-6l was consistent with that reported above for 6l. (4S, . This was prepared according to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10.8 mg, 9, 150.2, 147.74, 147.69, 146.4, 129.6, 129.4, 122.3, 122.1, 109.2, 109.0, 108.20, 108.18, 101.01, 100.99, 82.6, 60.6, 53.7, 41.8, 38.8, 28.2; IR (neat) v 3285, 2331 IR (neat) v 3285, , 1769 IR (neat) v 3285, , 1490 IR (neat) v 3285, , 1341 IR (neat) v 3285, , 1242 IR (neat) v 3285, , 1188 IR (neat) v 3285, , 1037 4, 150.3, 136.5, 136.1, 134.1, 134.0, 130.52, 130.48, 130.45, 129.6, 126.9, 126.8, 126.0, 125.9, 82.5, 58.3, 51.5, 39.0, 36.6, 28.1, 19.2, 18.9; IR (neat) v 3298, 2331 IR (neat) v 3298, , 1772 IR (neat) v 3298, , 1700 IR (neat) v 3298, , 1456 IR (neat) v 3298, , 1340 IR (neat) v 3298, , 1243 IR (neat) v 3298, , 1151 (4S, . This was prepared according to the general procedure using 5 (40.0 mg, 0.14 mmol) and CuBr·SMe 2 (10.8 mg, 0.053 mmol) in THF (4.6 mL) and a solution of 3-chlorophenylmagnesium chloride (0.64 M in THF, 0.80 mL, 0.51 mmol). Flash chromatography (two iterations were required: 2.0 g silica, 25%
EtOAc/hexanes) gave 6p (22.4 mg, 37%) as a colorless gum. TLC (30% EtOAc/pet ether) R F = 0. 6, 150.1, 137.8, 137.5, 134.53, 134.51, 129.9, 129.2, 129.0, 127.31, 127.29, 127.1, 82.9, 60.3, 53.5, 41.7, 38.8, 28 3302, 2328, 1762, 1574, 1424, 1337, 1198, 1148, 1050, 786 
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